Principal Financial Group
IRMD icon

Principal Financial Group’s iRadimed IRMD Stock Holding History

Principal Financial Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$937K Buy
9,732
+1,245
+15% +$125K ﹤0.01% 1954
2025
Q4 		$826K Buy
8,487
+2,560
+43% +$220K ﹤0.01% 1984
2025
Q3 		$422K Buy
+5,927
New +$395K ﹤0.01% 2078
2025
Q2 		– Sell
-5,460
Closed -$287K – 2269
2025
Q1 		$287K Buy
5,460
+20
+0.4% +$1.12K ﹤0.01% 2001
2024
Q4 		$299K Buy
5,440
+546
+11% +$28.7K ﹤0.01% 2034
2024
Q3 		$246K Buy
+4,894
New +$226K ﹤0.01% 2067

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group's IRMD Position: Q1 2026 in Review

Principal Financial Group increased its iRadimed (IRMD) stake by 15% in Q1 2026, buying an estimated $125K and bringing the position to 9,732 shares worth $937K. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Principal Financial Group first reported a position in IRMD in Q3 2024 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Principal Financial Group held 9,732 shares of iRadimed worth $937K as of Q1 2026.
  • Principal Financial Group bought 1,245 iRadimed shares in Q1 2026, an estimated $125K.
  • iRadimed made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #1954 holding.
  • Principal Financial Group first reported a position in iRadimed in Q3 2024 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.